Global Aptamers Market development technologies, increasing Research and development expenditure, and an increasing number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Abundant advantages offered by these small molecules, in comparison to established antibodies, have also led to higher demand for these molecules across a wide range of medical applications.
The Global Aptamers Market is expected to register a growth of significant CAGR 20.2% during the forecast period (2018–2023).
Key Players
Some of the key players in the global aptamers market are Aptamer Sciences, Inc., Aptagen, LLC, Base Pair Biotechnologies, Inc., Ophthotech Corporation, Am Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Neoventures Biotechnology Inc., Somalogic, Inc., Trilink Biotechnologies, Inc., Vivonics, Inc., Noxxon Pharma, and others.
Inquire for Sample Copy of this Report https://www.marketresearchfuture.com/sample_request/6630
Regional Analysis
The Americas is projected to lead the aptamers market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market.
The European market is expected to hold the second largest market share. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.
Asia-Pacific is projected to be the fastest growing region for the global aptamers in 2018. The market is expected to register positive growth owing to enlarged opportunities in diagnostics and development of pharmaceuticals which remain untapped in the aptamers market.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Global Aptamers Market, by Type
- Nucleic acid aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- Peptide aptamers
Global Aptamers Market, by Application
- Diagnostics
- Therapeutics development
- Research and development
- Other applications
Global Aptamers Market, by Technology
- Selex
- X-aptamer
- MARAS technique
Global Aptamers Market, by End Users
- Academic and government research institutes
- Biotechnology and pharmaceutical companies
- Contract research organizations
- Other end users
However, aptamers have failed to meet the necessary safety and efficacy standards in clinical studies. Thus, companies had to terminate their clinical investigation during late-stage clinical studies. This factor is likely to hamper the growth of this market. In addition, other factors, such as little awareness about these technologies in middle and low-income countries and inadequate regulatory structure, may hinder the overall growth.
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/aptamers-market-6630
Pune, India, November 2018/MRFR Press Release/- Market Research Future published a half-cooked research report on the Global Aptamers Market.
Intended Audience
- Manufacturers and distributors
- Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
- Research institutes
- Contract manufacturing organizations (CMOs)
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com